Zobrazeno 1 - 10 of 18 pro vyhledávání: '"Xu-Geng Wang"'
1
Akademický článek
Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report
Autor: Bai-Yan Wang, Wan-Hong Zhao, Yin-Xia Chen, Xing-Mei Cao, Yun Yang, Yi-Lin Zhang, Fang-Xia Wang, Peng-Yu Zhang, Bo Lei, Liu-Fang Gu, Jian-Li Wang, Ju Bai, Yan Xu, Xu-Geng Wang, Rui-Li Zhang, Li-Li Wei, Qiu-Chuan Zhuang, Frank Fan, Wang-Gang Zhang, Ai-Li He, Jie Liu
Publikováno v: Journal of Medical Case Reports, Vol 16, Iss 1, Pp 1-8 (2022)
Abstract Background Multiple myeloma remains incurable despite treatment advancements over the last 20 years. LCAR-B38M Cells in Treating Relapsed/Refractory Multiple Myeloma was a phase 1, first-in-human, investigator-initiated study in relapsed/ref
Externí odkaz: https://doaj.org/article/c9b293fef2f645698bfc3549329d7fc0
Zobrazit plný text záznamu
2
Akademický článek
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Autor: Wan-Hong Zhao, Jie Liu, Bai-Yan Wang, Yin-Xia Chen, Xing-Mei Cao, Yun Yang, Yi-Lin Zhang, Fang-Xia Wang, Peng-Yu Zhang, Bo Lei, Liu-Fang Gu, Jian-Li Wang, Nan Yang, Ru Zhang, Hui Zhang, Ying Shen, Ju Bai, Yan Xu, Xu-Geng Wang, Rui-Li Zhang, Li-Li Wei, Zong-Fang Li, Zhen-Zhen Li, Yan Geng, Qian He, Qiu-Chuan Zhuang, Xiao-Hu Fan, Ai-Li He, Wang-Gang Zhang
Publikováno v: Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-8 (2018)
Abstract Background Chimeric antigen receptor (CAR) T cell therapy has demonstrated proven efficacy in some hematologic cancers. We evaluated the safety and efficacy of LCAR-B38M, a dual epitope-binding CAR T cell therapy directed against 2 distinct
Externí odkaz: https://doaj.org/article/465fd456636849ce93bd874e19984b0a
Zobrazit plný text záznamu
3
Identification and functional study of novel oligonucleotides: CpG Seq 13 and CpG Seq 19
Autor: Nan Yang, Wanggang Zhang, Xu-Geng Wang, Yang Zhang, Hui Zhang, Jin Wang, Huan Yao, Shan Meng, Yueli Wang, Hailing Liu, Ting Wang, She-Ping Chen, Jinqiu Chen, Bo Lei
Publikováno v: Immunotherapy. 13:571-585
Aim: This study explored new immunoadjuvants with stronger immune activity to enhance therapeutic effects against leukemia. Materials & methods: Whole blood and bone marrow of acute myeloid leukemia (AML) patients and healthy volunteers were collecte
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5711a2adf4321acb6cbbd90f4d34b974
https://doi.org/10.2217/imt-2019-0197
Zobrazit plný text záznamu
6
A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma
Autor: Zongfang Li, Wanggang Zhang, Rui-Li Zhang, Yan Geng, Qiu-Chuan Zhuang, Yun Yang, Baiyan Wang, Hui Zhang, Yin-Xia Chen, Jie Liu, Zhenzhen Li, Qian He, Ju Bai, Li-Li Wei, Pengyu Zhang, Jianli Wang, Liufang Gu, Xing-Mei Cao, Nan Yang, Yi-Lin Zhang, Xiao-Hu Fan, Ying Shen, Xu-Geng Wang, Yan Xu, Bo Lei, Fang-Xia Wang, Ru Zhang, Wan-Hong Zhao, Aili He
Publikováno v: Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-8 (2018)
Journal of Hematology & Oncology
Background Chimeric antigen receptor (CAR) T cell therapy has demonstrated proven efficacy in some hematologic cancers. We evaluated the safety and efficacy of LCAR-B38M, a dual epitope-binding CAR T cell therapy directed against 2 distinct B cell ma
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fd6e3b75bbb9aca36cc235143205f45
http://link.springer.com/article/10.1186/s13045-018-0681-6
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje